Advertisement

Commentary: Brutus, Cassius, the Stars, and the Lung Cancer Screening Criteria

      To make lung cancer screening more equitable and effective, more research must be done to examine the usefulness of additional risk factors and establish different screening eligibility criteria.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Brenner H
        • Krilaviciute A.
        Commonly applied selection criteria for lung cancer screening may have strongly varying diagnostic performance in different countries.
        Cancers (Basel). 2020; : 12
        • Thomas N.A.
        • Tanner N.T.
        Lung cancer screening: Patient selection and implementation.
        Clin Chest Med. 2020; 41: 87-97
        • National Lung Screening Trial Research T.
        • Aberle D.R.
        • Adams A.M.
        • et al.
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N Engl J Med. 2011; 365: 395-409
        • de Koning H.J.
        • van der Aalst C.M.
        • de Jong P.A.
        • et al.
        Reduced lung-cancer mortality with volume CT screening in a randomized trial.
        N Engl J Med. 2020; 382: 503-513
        • Huo B.
        • Manos D.
        • Xu Z.
        • et al.
        Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN).
        Semin Thorac Cardiovasc Surg. 2022; (in press)
        • Shakespeare W.
        Act I.
        Julius Caesar. 2022; Scene III: 140-141
        • Lariscy J.T.
        • Hummer R.A.
        • Rogers R.G.
        Lung cancer mortality among never-smokers in the United States: Estimating smoking-attributable mortality with nationally representative data.
        Ann Epidemiol. 2020; 45: 5-11
        • Bertolaccini L.
        • Ciani O.
        • Spaggiari L.
        Comment on The unbearable lightness of difference between statistical and clinical significance.
        Ann Surg Open. 2022; 3: e114
        • Bernard A.
        • Falcoz P.E.
        • Thomas P.A.
        • et al.
        Comparison of Epithor clinical national database and medico-administrative database to identify the influence of case-mix on the estimation of hospital outliers.
        PLoS One. 2019; 14e0219672

      Linked Article

      • Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN)
        Seminars in Thoracic and Cardiovascular Surgery
        • Preview
          The SCREEN study investigated screening eligibility and survival outcomes between heavy smokers and light-or-never-smokers with lung cancer to determine whether expanded risk factor analysis is needed to refine screening criteria. SCREEN is a retrospective study of 917 lung cancer patients diagnosed between 2005 and 2018 in Nova Scotia, Canada. Screening eligibility was determined using the National Lung Screening Trial (NSLT) criteria. Mortality risk between heavy smokers and light-or-never-smokers was compared using proportional-hazards models.
        • Full-Text
        • PDF